主營(yíng)產(chǎn)品:醫(yī)藥中間體研發(fā)、生產(chǎn)、分裝及銷售(不含藥品及危險(xiǎn)化合物),生化制品銷售(不含危險(xiǎn)化學(xué)品),生物醫(yī)藥研發(fā)及技術(shù)轉(zhuǎn)讓,分析方法開發(fā)及技術(shù)轉(zhuǎn)讓,分析檢測(cè)服務(wù),
客服熱線:13915962545
1YR企業(yè)會(huì)員
英文名稱 | 中文名稱 | CAS號(hào) | 操作 |
1H-Isoindole-1,3(2H)-dione, 5-amino-2-[2,6-bis(1-methylethyl)phenyl]- | 5-氨基-2-(2,6-二異丙基苯基)異吲哚啉-1,3-二酮 | 100823-03-8 | 詳細(xì) |
TJ191 | 2-氨基-5-庚基噻吩-3-羧酸甲酯 | 1522415-97-9 | 詳細(xì) |
DC260126 | N-(4-BUTYLPHENYL)-4-FLUOROBENZENESULFONAMIDE | 346692-04-4 | 詳細(xì) |
1,5,7,8-TETRAHYDRO-2-METHYL-4H-THIOPYRANO[4,3-D]PYRIMIDIN-4-ONE | 3,5,7,8-四氫-2-甲基-4H-硫代吡喃并[4,3-D]嘧啶-4-酮 | 284028-90-6 | 詳細(xì) |
7-(4-TERT-BUTYLBENZYL)-1,3-DIMETHYL-3,7-DIHYDRO-1H-PURINE-2,6-DIONE | 7-(4-(叔丁基)芐基)-1,3-二甲基-1H-嘌呤-2,6(3H,7H)-二酮 | 333415-38-6 | 詳細(xì) |
n-vanillyldecanide. | 癸酸香草酰胺 | 31078-36-1 | 詳細(xì) |
CP 31398 | N3-[2-(4-甲氧基苯基)乙烯基]-4-喹唑啉基]-N1,N1-二甲基-1,3-丙二胺 | 259199-65-0 | 詳細(xì) |
2,2-Diphenyl-N-[4-(thiazol-2-ylsulfamoyl)-phenyl]-acetamide | 2,2-二苯基-N-(4-(N-(噻唑-2-基)氨磺?;?苯基)乙酰胺 | 313254-51-2 | 詳細(xì) |
ML 351 | 5-(甲基氨基)-2-(萘-1-基)惡唑-4-甲腈 | 847163-28-4 | 詳細(xì) |
EML 425. | 1675821-32-5 | 1675821-32-5 | 詳細(xì) |
Benzeneacetonitrile, 4-cyano-α-[[4-[(2-hydroxyethyl)methylamino]phenyl]methylene]- | HBC 530,用于在活細(xì)胞中對(duì)RNA成像的GFP熒光團(tuán)類似物 | 156840-13-0 | 詳細(xì) |
Benzonitrile, 3,3'-[(2-oxo-1,3-cyclohexanediylidene)dimethylidyne]bis- (9CI) | 3,3'-((2-氧代環(huán)己烷-1,3-二亞甲基)雙(甲基亞甲基))二苯甲腈 | 63476-70-0 | 詳細(xì) |
4-(4-FLUOROBENZOYL)-1-(4-PHENYLBUTYL)PIPERIDINE OXALATE | 4-(4-氟苯甲?;?-1-(4-苯基丁基)哌啶草酸鹽 | 144734-36-1 | 詳細(xì) |
2'-amino-3'-cyano-1-methyl-1,3,5',6',7',8'-hexahydro-2,5'-dioxospiro[2H-indol-3,4'-(4'H)-chromene] | 2-氨基-1'-甲基-2',5--二氧代-5,6,7,8-四氫螺[苯并吡喃-4,3'-吲哚啉]-3-甲腈 | 445222-91-3 | 詳細(xì) |
Simufilam dihydrochloride | 1-芐基-8-甲基-1,4,8-三氮雜螺[4.5]癸烷-2-酮二鹽酸鹽 | 2480226-06-8 | 詳細(xì) |
1,7,9-Triazaspiro[4.5]dec-1-ene-6,10-dione, 2,4-bis(4-chlorophenyl)-8-thioxo- | 2,4-雙(4-氯苯基)-8-硫代-1,7,9-三氮雜螺[4.5]癸-1-烯-6,10-二酮 | 2377858-38-1 | 詳細(xì) |
A 286982 | (E)-1-(4-乙?;哙?1-基)-3-(4-((2-異丙基苯基)硫基)-3-硝基苯基)丙-2-烯-1-酮 | 280749-17-9 | 詳細(xì) |
XEN723 | 2-(3-(4-氟芐基)-2-氧代咪唑烷-1-基)-4-甲基-N-(吡啶-3-基甲基)噻唑-5-甲酰胺 | 1072803-08-7 | 詳細(xì) |
CL 82198 HYDROCHLORIDE | N-(4-嗎啉丁基)苯并呋喃-2-甲酰胺 | 307002-71-7 | 詳細(xì) |
PF-6274484 | PF 6274484,共價(jià)EGFR激酶抑制劑 | 1035638-91-5 | 詳細(xì) |
8-Nitrotryptanthrin | 8-硝基吲哚并[2,1-b]喹唑啉-6,12-二酮 | 77603-42-0 | 詳細(xì) |
N-(4-Fluorophenyl)-4-phenyl-2-thiazolamine | UCLA GP130 2,gp130激動(dòng)劑 | 339303-87-6 | 詳細(xì) |
nec-34i | 2-((3-氰基-6-氧代-4-(對(duì)甲苯基)-1,4,5,6-四氫吡啶-2-基)硫基)-N-苯基乙酰胺 | 2212541-00-7 | 詳細(xì) |
2-{[3-cyano-4-(4-methylphenyl)-6-oxo-1,4,5,6-tetrahydropyridin-2-yl]sulfanyl}-N-(1,3-thiazol-2-yl)acetamide | 2-((3-氰基-6-氧代-4-(對(duì)甲苯基)-1,4,5,6-四氫吡啶-2-基)硫基)-N-(噻唑-2-基)乙酰胺 | 375835-43-1 | 詳細(xì) |
SRS16-86 | (Z)-4-(金剛烷-1-基氨基)-3-((嘧啶-5-基亞甲基)氨基)苯甲酸叔丁酯 | 1793052-96-6 | 詳細(xì) |
PRL-3 INHIBITOR I | 5-(5-溴-2-((2-溴芐基)氧基)苯亞甲基)-2-硫代噻唑烷-4-酮 | 893449-38-2 | 詳細(xì) |
FIDAS-3 | (E)-4-(2,6-二氟苯乙烯基)-N,N-二甲基苯胺 | 1266684-01-8 | 詳細(xì) |
BPAM344 >=98% (HPLC) | 4-環(huán)丙基-7-氟-3,4-二氫-2H-苯并[e][1,2,4]噻二嗪 1,1-二氧化物 | 1204572-55-3 | 詳細(xì) |
N-[4-[4-(2,3-DICHLOROPHENYL)-1-PIPERAZINYL]BUTYL]-9H-FLUORENE-2-CARBOXAMIDE HYDROCHLORIDE | N-[4-[4-(2,3-二氯苯基)-1-哌嗪基丁基]-9H-芴-2-甲酰胺 | 189060-98-8 | 詳細(xì) |
GV-58 | (R)-2-((6-(((5-甲基噻吩-2-基)甲基)氨基)-9-丙基-9H-嘌呤-2-基)氨基)丁-1-醇 | 1402821-41-3 | 詳細(xì) |
AMN082 DIHYDROCHLORIDE | N1,N2-二苯甲基乙烷-1,2-二胺 | 83027-13-8 | 詳細(xì) |
N-(5-methyl-1,2-oxazol-3-yl)-2-phenyl-2-(1,2,3,4-tetrahydroquinolin-1-yl)acetamide | CIM 0216,TRPM3激動(dòng)劑 | 1031496-06-6 | 詳細(xì) |
9H-INDENO[1,2-B]PYRAZINE-2,3-DICARBONITRILE, 9-[(2-PROPEN-1-YLOXY)IMINO]- | 9-((烯丙氧基)亞氨基)-9H-茚并[1,2-b]吡嗪-2,3-二甲腈 | 924296-17-3 | 詳細(xì) |
DUBs-IN-2 | 9-乙氧基亞氨基-9H-茚并[1,2-b]吡嗪-2,3-二甲腈 | 924296-19-5 | 詳細(xì) |
(±)-2-(1H-benzimidazol-2-ylthio)propanoicacid2-[(5-bromo-2-hydroxyphenyl)methylene]hydrazide | 2-((1H-苯并[d]咪唑-2-基)硫基)-N'-(5-溴-2-羥基苯亞甲基)丙烷酰肼 | 330676-02-3 | 詳細(xì) |
NSC232003 | 5-(1-(羥基氨基)亞乙基)嘧啶-2,4(3H,5H)-二酮 | 1905453-18-0 | 詳細(xì) |
YK-3-237 | YK 3-237,SIRT1激活劑 | 1215281-19-8 | 詳細(xì) |
2-Propenamide, 3-(3-chlorophenyl)-N-[2-[4-(methylsulfonyl)-1-piperazinyl]-2-oxoethyl]-, (2E)- | (2E)-3-(3-氯苯基)-N-[2-[4-(甲基磺酰基)-1-哌嗪基]-2-氧代乙基]-2-丙酰胺 | 2505001-54-5 | 詳細(xì) |
(E)-3-(3,4-dichlorophenyl)-N-(2-(4-(methylsulfonyl)piperazin-1-yl)-2-oxoethyl)acrylamide | (E)-3-(3,4-二氯苯基)-N-(2-(4-(甲基磺?;?哌嗪-1-基)-2-氧代乙基)丙烯酰胺 | 2505001-62-5 | 詳細(xì) |
Thiocyanic acid, 2-(3,4-dihydroxyphenyl)-2-oxoethyl ester (9CI) | 硫氰酸 2-(3,4-二羥基苯基)-2-氧代乙酯 | 101714-41-4 | 詳細(xì) |
Liarozole | 膠唑. | 115575-11-6 | 詳細(xì) |
Acetic acid, 2-[[6-[2-(cyclohexylamino)-1-[[(4-methoxyphenyl)methyl](2-pyridinylcarbonyl)amino]-2-oxoethyl]-2-naphthalenyl]oxy]-, 1,1-dimethylethyl ester | 2-((6-(2-(環(huán)己基氨基)-1-(N-(4-甲氧基芐基)吡啶-2-甲酰胺基)-2-氧代乙基)萘-2-基)氧基)乙酸叔丁酯 | 886053-73-2 | 詳細(xì) |
ML318 | 2-(4-氟苯基)-2-(6-(三氟甲基)吡啶-2-基)乙腈 | 1610516-67-0 | 詳細(xì) |
Benzoic acid, 2,4-dichloro-, 5-nitro-8-quinolinyl ester | 5-硝基喹啉-8-基2,4-二氯苯甲酸酯 | 311316-96-8 | 詳細(xì) |
TSHR antagonist S37 | 7,10-二苯基-3,4a,5,5a,8a,9,9a,10-八氫-5,9-甲橋噻唑并[5',4':5,6]硫代吡喃并[2,3-f]異吲哚-2,6,8(7H)-三酮 | 1217616-61-9 | 詳細(xì) |
ML198 | N-(4-乙炔基苯基)-5,7-二甲基吡唑并[1,5-a]嘧啶-3-甲酰胺 | 1380716-06-2 | 詳細(xì) |
3-AMINO-N-[(4-CHLOROPHENYL)METHYL]-4,6-DIMETHYLTHIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE | 3-氨基-N-(4-氯芐基)-4,6-二甲基噻吩并[2,3-b]吡啶-2-甲酰胺 | 633283-39-3 | 詳細(xì) |
4-acetamido-N-(2-amino-5-(thiophen-2-yl)phenyl)benzamide | 4-乙酰胺基-N-(2-氨基-5-(噻吩-2-基)苯基)苯甲酰胺 | 849234-64-6 | 詳細(xì) |
SMIFH2 | SMIFH2 Formin FH2域抑制劑 | 340316-62-3 | 詳細(xì) |
EPPTB | N-(3-乙氧基苯基)-4-(吡咯烷-1-基)-3-(三氟甲基)苯甲酰胺 | 1110781-88-8 | 詳細(xì) |
NSC764414 | 4-[O-[(4-甲氧基苯基)磺酰基]肟] -2,6-二甲基-2,5-環(huán)己二烯-1,4-二酮 | 321695-57-2 | 詳細(xì) |
2-(2-CHLORO-4-IODOPHENYLAMINO)-3,4-DIFLUOROBENZOIC ACID | 2-((2-氯-4-碘苯基)氨基)-3,4-二氟苯甲酸 | 303175-44-2 | 詳細(xì) |
9H-Carbazole, 9-[3-(3,5-dimethyl-1-piperazinyl)propyl]-, (3R-trans)- (9CI) | 9H-咔唑,9-[3-(3,5-二甲基-1-哌嗪基)丙基]-,(3R-Trans)- | 95586-99-5 | 詳細(xì) |
(5E)-1-(3-chloro-4-methylphenyl)-5-[(2E)-3-(furan-2-yl)prop-2-en-1-ylidene]-2-thioxodihydropyrimidine-4,6(1H,5H)-dione | 1-(3-氯-4-甲基苯基)-5-(3-(呋喃-2-基)亞烯丙基)-2-硫代二氫嘧啶-4,6(1H,5H)-二酮 | 593273-05-3 | 詳細(xì) |
1-Methyl-1-[4-(4-trifluoromethoxy-phenyl)-1H-imidazol-2-yl]-ethylamine | 2-(4-(4-(三氟甲氧基)苯基)-1H-咪唑-2-基)丙-2-胺 | 1480833-70-2 | 詳細(xì) |
1-Piperidinecarboxylic acid, 4-nitrophenyl ester | 哌啶-1-甲酸對(duì)硝基苯酯 | 65815-76-1 | 詳細(xì) |
JP 1302 2HCl | JP1302二鹽酸鹽 | 1259314-65-2 | 詳細(xì) |
AAK1 inhibitor 1 | N-[6-[3-[[(二乙基氨基)磺酰]氨基]苯基]-1H-吲唑-3-基]環(huán)丙烷甲酰胺 | 2247894-32-0 | 詳細(xì) |
Ca2+ channel agonist 1 | (R)-2-((6-(芐基氨基)-9-丙基-9H-嘌呤-2-基)氨基)丁-1-醇 | 1402821-24-2 | 詳細(xì) |
DPPE FUMARATE | DPPE fumarate,抑制劑 | 1185241-83-1 | 詳細(xì) |
2-([2-(4-CHLOROPHENOXY)ETHYL]THIO)-1H-BENZIMIDAZOLE | 2-[2-(4-氯-苯氧基)-乙基硫基]-1H-苯并咪唑 | 312749-73-8 | 詳細(xì) |
TYRPHOSTIN AG 835 | (2E)-2-氰基-3-(3,4-二羥基苯基)-N-[(1S)-1-苯基乙基]-2-丙烯酰胺 | 133550-37-5 | 詳細(xì) |
SEN 12333 | SEN 12333,α7煙堿乙酰膽堿受體(nAChR)激動(dòng)劑 | 874450-44-9 | 詳細(xì) |
1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol:hydrochloride | Naftopidil hydrochloride,α1拮抗劑 | 1164469-60-6 | 詳細(xì) |
1H-PeriMidine,2-(4-broMophenyl)-2,3-dihydro- | 2-(4-溴苯基)-2,3-二氫-1H-呸啶 | 64369-13-7 | 詳細(xì) |
4-chloro-2-(2-(2-chlorophenoxy)acetamido)benzoic acid | 4-氯-2-(2-(2-氯苯氧基)乙酰氨基)苯甲酸 | 351424-20-9 | 詳細(xì) |
Pimonidazole | Pimonidazole,缺氧檢測(cè)試劑 | 70132-50-2 | 詳細(xì) |
pimonidazole | 1-哌啶甲醇,α-[(2-硝基-1H-咪唑-1-基)甲基]-,鹽酸鹽(1:1) | 70132-51-3 | 詳細(xì) |
3-[(2-Pyridinyl)methylene]indolin-2-one | 3-(吡啶-2-基亞甲基)吲哚啉-2-酮 | 3367-88-2 | 詳細(xì) |
2-(3,4-dichlorophenyl)-N-[4-(1,2-oxazol-3-ylsulfamoyl)phenyl]acetamide | 2-(3,4-二氯苯基)-N-(4-(N-(異惡唑-3-基)氨磺?;?苯基)乙酰胺 | 1486482-16-9 | 詳細(xì) |
(3-bromophenyl)-(4-pyrrolidin-1-ylpiperidin-1-yl)methanone:hydrochloride | UNC 926 鹽酸鹽 | 1782573-49-2 | 詳細(xì) |
HEXAMETHYLENE-BIS-[DIMETHYL-(3-PHTHALIMIDOPROPYL)AMMONIUM]DIBROMIDE | N1,N6-雙(3-(1,3-二氧代異吲哚啉-2-基)丙基)-N1,N1,N6,N6-四甲基己烷-1,6-二銨溴化物 | 21093-51-6 | 詳細(xì) |
WH-4-025 | 2-甲基-5-((3-(三氟甲基)苯基)氨基甲?;?苯基 (2,4-二甲氧基苯基)(2-((4-(4-甲基哌嗪-1-基)苯基)氨基)嘧啶-4-基)氨基甲酸酯 | 1876463-35-2 | 詳細(xì) |
N-[3-(benzylamino)-1,4-dioxo-1,4-dihydronaphthalen-2-yl]-N-[(4-fluorophenyl)methyl]acetamide | N-(3-(芐基氨基)-1,4-二氧-1,4-二氫萘-2-基)-N-(4-氟芐基)乙酰胺 | 355406-76-7 | 詳細(xì) |
DIACYLGLYCEROL KINASE INHIBITOR II | 3-(2-(4-(雙(4-氟苯基)亞甲基)哌啶-1-基)乙基)-2-硫代-2,3-二氫喹唑啉-4(1H)-酮 | 120166-69-0 | 詳細(xì) |
TFMB-(R)-2-HG | 3-(三氟甲基)芐基 (R)-5-氧代四氫呋喃-2-羧酸酯 | 1445700-01-5 | 詳細(xì) |
SBC-115337 | N-(4-((4-(苯并[d]惡唑-2-基)苯基)氨基甲?;?苯基)苯并呋喃-2-甲酰胺 | 423148-46-3 | 詳細(xì) |
Fluorofenidone | 1-(3-氟苯基)-5-甲基吡啶-2(1H)-酮 | 848353-85-5 | 詳細(xì) |
GUANABENZ HYDROCHLORIDE | 肼氨基甲基咪唑,2-[(2,6-二氯苯基)亞甲基]-,鹽酸鹽(1:1) | 23113-43-1 | 詳細(xì) |
6-methyl-2-[2-[(E)-(6-oxo-1-cyclohexa-2,4-dienylidene)methyl]hydraziny l]-1H-pyrimidin-4-one | 2-(2-(2-羥基亞芐基)肼基)-6-甲基嘧啶-4-醇 | 66680-03-3 | 詳細(xì) |
MP-A08 | 4-甲基-N-(2-((2-((4-甲基苯基)磺酰胺基)亞芐基)氨基)苯基)苯磺酰胺 | 219832-49-2 | 詳細(xì) |
3-[1-Methyl-4-(4-morpholinyl)-1H-pyrazolo[3,4-d]pyrimidin-6-ylphenol | 3-[1-甲基-4-(4-嗎啉基)-1H-吡唑并[3,4-d]嘧啶-6-基]苯酚 | 1198357-79-7 | 詳細(xì) |
[1,1'-Biphenyl]-4-carboxaMide, N-[5-[[iMino[(3,4,5-triMethoxybenzoyl)aMino]Methyl]aMino]-2-Methylphenyl]- | N-(2-甲基-5-(3-(3,4,5-三甲氧基苯甲酰基)胍基)苯基)-[1,1'-聯(lián)苯]-4-甲酰胺 | 1263131-92-5 | 詳細(xì) |
2,4,6-TRIMETHYL-N-[2-(TRIFLUOROMETHYL)PHENYL]BENZENESULFONAMIDE | 2,4,6-三甲基-N-(2-(三氟甲基)苯基)苯磺酰胺 | 313981-55-4 | 詳細(xì) |
2-Phenoxybenzoicacid-[(5-methyl-2-furanyl)methylene]hydrazide | N'-((5-甲基呋喃-2-基)亞甲基)-2-苯氧基苯甲酰肼 | 113906-27-7 | 詳細(xì) |
3,4,5-trimethoxy-N-[[4-methyl-3-[(4-phenylbenzoyl)amino]phenyl]carbamothioyl]benzamide | N-(2-甲基-5-(3-(3,4,5-三甲氧基苯甲?;?硫脲基)苯基)-[1,1'-聯(lián)苯]-4-甲酰胺 | 1263132-08-6 | 詳細(xì) |
YS 49 | 1-(萘-1-基甲基)-1,2,3,4-四氫異喹啉-6,7-二醇?xì)滗逅猁} | 132836-42-1 | 詳細(xì) |
TCN 213 | 2-((5-(芐氨基)-1,3,4-噻二唑-2-基)硫基)-N-(環(huán)己基甲基)乙酰胺 | 556803-08-8 | 詳細(xì) |
JW 642 | 1,1,1,3,3,3-六氟丙烷-2-基 4-(3-苯氧基芐基)哌嗪-1-羧酸酯 | 1416133-89-5 | 詳細(xì) |
JZL 195 | 4-硝基苯基4-(3-苯氧基芐基)哌嗪-1-甲酸叔丁酯 | 1210004-12-8 | 詳細(xì) |
INDEX NAME NOT YET ASSIGNED | 3,3'',4,4'',5,5''-六甲氧基-[1,1':3',1''-三聯(lián)苯]-5'-磷酸二氫酯 | 2582757-90-0 | 詳細(xì) |
GW 610 | 2-(3,4-二甲氧基苯基)-5-氟苯并[d]噻唑 | 872726-44-8 | 詳細(xì) |
5-(5-Fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic Acid | 5-(5-氟-2-氧代-1,2-二氫-吲哚-3-亞基甲基)-2,4-二甲基-1H-吡咯-3-羧酸 | 452105-33-8 | 詳細(xì) |
Alkyne tyramide | N-(4-羥基苯乙基)戊-4-炔酰胺 | 1694495-59-4 | 詳細(xì) |
MK-2 Inhibitor III | 2-(2-(喹啉-3-基)吡啶-4-基)-6,7-二氫-1H-吡咯并[3,2-c]吡啶-4(5H)-酮水合物 | 1186648-22-5 | 詳細(xì) |
SR 1001 | N-(5-(N-(4-(1,1,1,3,3,3-六氟-2-羥基丙烷-2-基)苯基)氨磺?;?-4-甲基噻唑-2-基)乙酰胺 | 1335106-03-0 | 詳細(xì) |
Fosciclopirox | ((6-環(huán)己基-4-甲基-2-氧代吡啶-1(2H)-基)氧基)甲基 磷酸酯 | 1380539-06-9 | 詳細(xì) |
SP-8356 | (1S,5R)-4-[(1E)-2-(3,4-二羥基-5-甲氧基苯基)乙烯基]-6,6-二甲基二環(huán)[3.1.1]庚-3-烯-2-酮 | 1454885-45-0 | 詳細(xì) |
2-(3-Bromo-4-methoxyphenyl)-3-[(4-chlorophenyl)sulfonyl]-thiazolidine | 2-(3-溴-4-甲氧基苯基)-3-[(4-氯苯基)磺?;鵠噻唑烷 | 313669-88-4 | 詳細(xì) |
N-Cycloheptyl-N-(9H-fluoren-2-ylmethyl)-N'-(2,4,6-trimethylphenyl)urea | 1-((9H-芴-2-基)甲基)-1-環(huán)庚基-3-均三甲苯基脲 | 138046-43-2 | 詳細(xì) |
產(chǎn)品總數(shù):8827 產(chǎn)品頁碼: | ||||
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 |
商家暫時(shí)不對(duì)外公布